نبض الحدث

Higher dose Wegovy demonstrates nearly 28% weight loss in early responders according to new analyses presented at the European Congress on Obesity

Early responders (15% or more weight loss after 24 weeks) to the higher dose of Wegovy®️ (semaglutide 7.2 mg) achieved…

أكمل القراءة »

Redefining Flagship: HONOR 600 Series Brings Top-Tier Features Without the Top-Tier Cost

Smartphones today are no longer just tools; they are extensions of how people see, create, and share their lives. From…

أكمل القراءة »